1.
Sex differences in cardiometabolic disorders
by Gerdts, Eva
Nature medicine, 2019, Vol.25 (11), p.1657-1666
2.
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
by Tawakol, Ahmed, Dr
The Lancet (British edition), 2017, Vol.389 (10071), p.834-845
3.
HDL and cardiovascular disease
by Rader, Daniel J, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.618-625
4.
Brown adipose tissue is associated with cardiometabolic health
by Becher, Tobias
Nature medicine, 2021, Vol.27 (1), p.58-65
5.
Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis
by Kramer, Caroline K
Diabetologia, 2019, Vol.62 (6), p.905-914
6.
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
by Miranda, J Jaime
Nature medicine, 2019, Vol.25 (11), p.1667-1679
7.
Eph Receptors and Ephrins: Therapeutic Opportunities
by Barquilla, Antonio
Annual review of pharmacology and toxicology, 2015, Vol.55 (1), p.465-487
8.
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
by Brown, J. Mark
Annual review of medicine, 2015, Vol.66 (1), p.343-359
9.
The cellular and signaling networks linking the immune system and metabolism in disease
by Osborn, Olivia
Nature medicine, 2012, Vol.18 (3), p.363-374
10.
Vascular calcification: Mechanisms of vascular smooth muscle cell calcification
by Leopold, Jane A., MD
Trends in cardiovascular medicine, 2015, Vol.25 (4), p.267-274
11.
MicroRNAs in cardiovascular disease: an introduction for clinicians
by Romaine, Simon P R
Heart, 2015, Vol.101 (12), p.921-928
12.
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
by Griffin, Simon J
Diabetologia, 2017, Vol.60 (9), p.1620-1629
13.
Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model
by Aksentijevich, Milena
Trends in cardiovascular medicine, 2020, Vol.30 (8), p.472-478
14.
The Biology of ST2: The International ST2 Consensus Panel
by Pascual-Figal, Domingo A., MD
The American journal of cardiology, 2015, Vol.115 (7), p.3B-7B
15.
Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism
by Ahn, Chang Ho
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (8), p.2905-2913
16.
Mechanisms of Cardiovascular Remodeling in Hyperhomocysteinemia
by Steed, Mesia M.
Antioxidants & redox signaling, 2011, Vol.15 (7), p.1927-1943
17.
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
by Pavo, Noemi
Heart (British Cardiac Society), 2015, Vol.101 (23), p.1874-1880
18.
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
by Blaha, Michael J, Dr
The Lancet (British edition), 2011, Vol.378 (9792), p.684-692
19.
20.
Adiponectin: mechanistic insights and clinical implications
by Turer, A. T
Diabetologia, 2012, Vol.55 (9), p.2319-2326
